| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Moderna, Inc. | Director | Common Stock | 22.2K | $2.52M | $113.40 | May 3, 2024 | Direct |
| Moderna, Inc. | Director | Restricted Stock Units | 0 | $0 | $113.40 | May 3, 2024 | Direct |
| Seres Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 115K | Jul 1, 2024 | Direct | ||
| Moderna, Inc. | Director | Stock Option (Right to Buy) | 7.56K | May 6, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| MCRB | Seres Therapeutics, Inc. | Jul 1, 2024 | 1 | $0 | 4 | Jul 3, 2024 | Director |
| MRNA | Moderna, Inc. | May 3, 2024 | 3 | $0 | 4 | May 7, 2024 | Director |
| MCRB | Seres Therapeutics, Inc. | Apr 4, 2024 | 1 | $0 | 4 | Apr 8, 2024 | Director |
| MCRB | Seres Therapeutics, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| MRNA | Moderna, Inc. | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
| MRNA | Moderna, Inc. | Apr 28, 2023 | 2 | $0 | 4 | May 1, 2023 | Director |
| MCRB | Seres Therapeutics, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
| MRNA | Moderna, Inc. | Apr 28, 2022 | 4 | $0 | 4 | May 2, 2022 | Director |
| MRNA | Moderna, Inc. | Aug 19, 2021 | 1 | $0 | 4 | Aug 20, 2021 | Director |
| MCRB | Seres Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |